iCAD, INC. (NASDAQ:ICAD)

CAPS Rating: 5 out of 5

The Company designs, develops, manufactures and markets Computer-Aided Detection solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier.

Recs

0
Player Avatar Stepkonyc (93.37) Submitted: 6/24/2007 7:46:32 AM : Outperform Start Price: $3.75 ICAD Score: -79.73

A necessary technology that can only improve with time.

Featured Broker Partners


Advertisement